Filtros de búsqueda

Lista de obras de Alain Ravaud

A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study.

artículo científico publicado en 2017

A phase III trial of docetaxel-estramustine in high-risk localised prostate cancer: a planned analysis of response, toxicity and quality of life in the GETUG 12 trial.

artículo científico publicado en 2011

A prospective observational study on the evaluation of everolimus-related adverse events in metastatic renal cell carcinoma after first-line anti-vascular endothelial growth factor therapy: the AFINITE study in France

artículo científico publicado en 2017

A survey in general practice about undergraduate cancer education: results from Gironde (France)

artículo científico publicado en 1991

AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney: a randomized, double-blind, placebo-controlled, phase 2 study.

artículo científico publicado en 2012

Adaptation of multidisciplinary meeting decisions in a medical oncology department during the COVID epidemic in a less affected region of France: a prospective analysis from Bordeaux University Hospital

scientific article published on 16 June 2020

Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results.

artículo científico publicado en 2017

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy

artículo científico publicado en 2016

Adjuvant therapy by BCG of non-Hodgkin's malignant lymphomas in a controlled trial: an update

artículo científico publicado en 1989

Adverse effects of interleukin 2

artículo científico publicado el 1 de noviembre de 1991

Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer

artículo científico publicado en 2014

Amplification of epidermal growth factor receptor gene in renal cell carcinoma

article

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial

artículo científico publicado en 2015

Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.

artículo científico publicado en 2013

Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial

artículo científico publicado en 2017

Are we ready for day-case partial nephrectomy?

artículo científico publicado en 2015

Arterial hypertension and clinical benefit of sunitinib, sorafenib and bevacizumab in first and second-line treatment of metastatic renal cell cancer.

artículo científico publicado en 2009

Assessing the impact of evolving evidence in renal cell carcinoma treatment: an update of the Renal Cell Carcinoma Appropriateness-based Treatment Toolkit (ReCATT).

artículo científico publicado en 2014

Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.

artículo científico publicado en 2002

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial

artículo científico publicado en 2017

Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis

artículo científico publicado en 2020

Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial

artículo científico publicado en 2017

Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study

artículo científico publicado en 2017

Axitinib: a review of its safety and efficacy in the treatment of adults with advanced renal cell carcinoma.

artículo científico

Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events

artículo científico publicado en 2021

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

artículo científico publicado en 2007

Bladder cancer and new drugs

artículo científico publicado en 2010

Bladder cancer in patients after organ transplantation.

scientific article published on September 2010

Cabozantinib: Mechanism of action, efficacy and indications

artículo científico publicado en 2017

Cancer chemotherapy in the elderly: a series of 51 patients aged greater than 70 years

artículo científico publicado en 1991

Cardiomyopathy after acute myocardial infarction after therapy with interleukin-2 and tumour infiltrating lymphocytes

artículo científico publicado en 1992

Case study of the month. Complete histologic remission after sunitinib neoadjuvant therapy in T3b renal cell carcinoma.

artículo científico publicado en 2009

Cell therapy in renal cell carcinoma

artículo científico publicado el 1 de agosto de 2003

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

artículo científico publicado en 2018

Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study

artículo científico publicado en 2015

Colonic metastasis of a renal carcinoma. A case report

artículo científico publicado en 1992

Combination of gemcitabine and doxorubicin in rapidly progressive metastatic renal cell carcinoma and/or sarcomatoid renal cell carcinoma

artículo científico publicado en 2011

Combination therapy in metastatic renal cell cancer.

artículo científico

Combined radiofrequency ablation and antiangiogenic drug for the treatment of recurrent renal tumor

artículo científico publicado en 2008

Cutaneous cryptococcosis with alemtuzumab in a patient treated for chronic lymphocytic leukaemia

scientific article published on 11 April 2007

Cytokines in metastatic renal cell carcinoma: is it useful to switch to interleukin-2 or interferon after failure of a first treatment? Groupe Français d'Immunothérape

scientific article published on 01 July 1999

Drug Interaction With Sunitinib and the Evidence of Therapeutic Drug Monitoring: A Case Report and Review of the Literature.

artículo científico publicado en 2017

Drug-induced pneumonitis in cancer patients treated with mTOR inhibitors: management and insights into possible mechanisms.

artículo científico

Editorial comment to therapy management of cardiovascular adverse events in the context of targeted therapy for metastatic renal cell carcinoma

artículo científico publicado en 2012

Effectiveness and safety of first-line bevacizumab plus FOLFIRI in elderly patients with metastatic colorectal cancer: Results of the ETNA observational cohort

artículo científico publicado en 2016

Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial.

artículo científico publicado en 2012

Efficacy of Rechallenge of Metastatic Renal Cell Carcinoma Patient With Sunitinib After Prior Resistance to Axitinib: Case Report and Review of the Literature

artículo científico publicado en 2016

Efficacy of re-challenging metastatic renal cell carcinoma with mTOR inhibitors.

artículo científico publicado en 2011

Efficacy of sunitinib in advanced medullary thyroid carcinoma: intermediate results of phase II THYSU.

artículo científico publicado en 2010

Emerging antiangiogenics for renal cancer.

artículo científico

Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: a RECORD-1 subgroup analysis

artículo científico publicado en 2012

Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study.

artículo científico publicado en 2011

Experimental characterization of subwavelength diffraction gratings by an inverse-scattering neural method

artículo científico publicado en 2002

Exposure-response relationships in patients with metastatic renal cell carcinoma receiving sunitinib: maintaining optimum efficacy in clinical practice.

artículo científico publicado en 2011

First-line bevacizumab combined with reduced dose interferon-alpha2a is active in patients with metastatic renal cell carcinoma

scientific article published on 11 April 2008

First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG)†.

artículo científico publicado en 2015

Functional decline in older patients with cancer receiving first-line chemotherapy

artículo científico publicado en 2013

Gastric lipase in alcoholic pancreatitis. Comparison of secretive profiles following pentagastrin stimulation in normal adults and patients with pancreatic insufficiency

artículo científico publicado en 1990

Gemcitabine or Gemcitabine Plus Oxaliplatin in the First-Line Treatment of Patients With Advanced Transitional Cell Carcinoma of the Urothelium Unfit for Cisplatin-Based Chemotherapy: A Randomized Phase 2 Study of the French Genitourinary Tumor Group

article

Granulocyte-macrophage colony-stimulating factor in established febrile neutropenia

scientific article published on 01 September 1999

Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial

scientific article published on 01 September 1998

Hand-foot syndrome and sorafenib

artículo científico publicado en 2009

High-dose interleukin-2 two days a week for metastatic renal cell carcinoma: a FNCLCC multicenter study

scientific article published on 01 November 1994

Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatment

artículo científico publicado en 2017

How to manage intravenous vinflunine in cancer patients with renal impairment: results of a pharmacokinetic and tolerability phase I study.

artículo científico publicado en 2014

How to optimise treatment compliance in metastatic renal cell carcinoma with targeted agents

artículo científico publicado en 2009

How to report toxicity associated with targeted therapies?

artículo científico publicado en 2016

Immune biomarkers predictive for disease-free survival with adjuvant sunitinib in high-risk locoregional renal cell carcinoma: from randomized phase III S-TRAC study.

artículo científico publicado en 2018

Immune checkpoint inhibitors and elderly people: A review

artículo científico publicado en 2017

Immunotherapy in head and neck cancer: Need for a new strategy? Rapid progression with nivolumab then unexpected response with next treatment

artículo científico publicado en 2016

In vitro immunization of patient T cells with autologous bone marrow antigen presenting cells pulsed with tumor lysates

scientific article published on 01 December 2000

In vitro production of human antigen presenting cells issued from bone marrow of patients with cancer

artículo científico publicado en 1997

Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma.

artículo científico

Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding.

artículo científico publicado en 1990

Interferon alpha for the treatment of advanced renal cancer.

artículo científico publicado en 2005

Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'Immunotherapie

artículo científico publicado en 2004

Intérêt des anti-angiogéniques dans le cancer du rein localement avancé et métastatique en situation néo-adjuvante : à propos de 2 cas

scientific article published on 01 July 2008

Investigation of total and conjugated bilirubin determination during the neonatal period

scientific article published on 01 August 1993

Is Multiparametric MRI Useful for Differentiating Oncocytomas From Chromophobe Renal Cell Carcinomas?

artículo científico publicado en 2016

Laparoscopic radical prostatectomy in renal transplant recipients.

artículo científico publicado en 2009

Lapatinib and renal cell carcinoma

artículo científico

Lowered Serum Dipeptidyl Peptidase IV Activity is Associated with Depressive Symptoms and Cytokine Production in Cancer Patients Receiving Interleukin-2-Based Immunotherapy

article

Lung tumors treated with percutaneous radiofrequency ablation: computed tomography imaging follow-up

scientific article published on 03 December 2010

L’imagerie d’évaluation thérapeutique en pratique clinique d’oncologie urologique

artículo científico publicado en 2014

Management of Immune Checkpoint Inhibitor Toxicities

scientific article published on 28 September 2020

Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma.

artículo científico publicado en 2011

Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial

artículo científico publicado en 2007

Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacy.

artículo científico publicado en 2016

Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response.

artículo científico publicado en 2017

Metronomic chemotherapy for renal cancer in the landscape of targeted therapy.

artículo científico publicado en 2010

Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers

artículo científico publicado en 2005

Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2.

artículo científico publicado en 2014

Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma

artículo científico publicado en 2014

Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic features

artículo científico publicado en 2015

New challenges in kidney cancer therapy: bevacizumab

artículo científico publicado en 2007

New entities in pathological classification and new therapeutic options in renal cell carcinoma

artículo científico publicado en 2006

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.

artículo científico publicado en 2018

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

artículo científico publicado en 2015

Néphrectomie partielle laparoscopique robot-assistée après traitement néoadjuvant

scientific article published on 30 October 2014

Optimal management of renal cell carcinoma in the elderly: a review

artículo científico

Oral and intravenously administered mTOR inhibitors for metastatic renal cell carcinoma: pharmacokinetic considerations and clinical implications.

artículo científico

Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinoma.

artículo científico publicado en 2014

Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials

artículo científico publicado en 2016

Overall survival in patients with metastatic renal cell carcinoma initially treated with bevacizumab plus interferon‐α2a and subsequent therapy with tyrosine kinase inhibitors: a retrospective analysis of the phase III AVOREN trial ⬇️

artículo científico publicado el 13 de octubre de 2010

PET scans for decision-making in metastatic renal cell carcinoma: a single-institution evaluation.

artículo científico publicado en 2006

Patients' self-assessment versus investigators' evaluation in a phase III trial in non-castrate metastatic prostate cancer (GETUG-AFU 15).

artículo científico publicado en 2014

Patterns of Use, Safety, and Effectiveness of Targeted Therapies in First-Line Treatment of Metastatic Colorectal Cancer According to Age: The STROMBOLI Cohort Study

artículo científico publicado en 2018

Pharmacodynamic and pharmacokinetic study of propranolol in patients with cirrhosis and portal hypertension.

artículo científico publicado en 1989

Phase I dose-escalation study of oral vinflunine administered once daily for 6 weeks every 8 weeks in patients with advanced/metastatic solid tumours.

artículo científico publicado en 2013

Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study

artículo científico publicado en 2005

Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study.

artículo científico publicado en 2017

Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancer

artículo científico publicado en 2003

Phase II study of interferon-alpha and all-trans retinoic acid in metastatic renal cell carcinoma

artículo científico publicado en 1998

Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state.

artículo científico publicado en 1999

Predictors of early death risk in older patients treated with first-line chemotherapy for cancer

artículo científico publicado en 2012

Present achievements in the medical treatment of metastatic renal cell carcinoma.

artículo científico publicado en 1999

Principles, modalities and indications of the administration of Radium in cancers, focus on metastatic prostate cancer: State of arts

artículo científico publicado en 2017

Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model

artículo científico publicado en 2014

Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract AE 941

artículo científico publicado en 2007

Prognostic factors of response or failure of treatment in patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie

scientific article published on 12 February 2005

Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie

scientific article published on 01 September 2002

Progression beyond nivolumab: Stop or repeat? Dramatic responses with salvage chemotherapy

artículo científico publicado en 2018

Prolonged efficacy of mTOR inhibitors in papillary renal cell carcinoma: progression-free survival lasting for over 3 years, a case report and review of the literature

artículo científico

Protein kinase inhibitors in renal cell carcinoma.

artículo científico publicado en 2013

Pulmonary arterial hypertension due to an intratumoral shunt: an unexpected side effect of sunitinib

artículo científico

Pulmonary aspergilloma: an unexpected complication of radiofrequency ablation in the management of targeted therapy for a patient with metastatic renal cell carcinoma.

artículo científico publicado en 2014

Quelle pratique de la néphrectomie partielle en France ?

article

RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma

artículo científico publicado en 2015

Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma ⬇️

artículo científico publicado en 2016

Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer.

artículo científico publicado en 2007

Randomized study of intravenous versus subcutaneous interleukin-2, and IFNalpha in patients with good prognosis metastatic renal cancer

scientific article published on 01 September 2008

Rationale for the local treatment of metastases

artículo científico publicado en 2011

Real-life patterns of use, safety and effectiveness of sunitinib in first-line therapy of metastatic renal cell carcinoma: the SANTORIN cohort study.

artículo científico publicado en 2017

Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie

scientific article published on 01 April 1998

Relationship between Pulmonary Adverse Events and Everolimus Exposure in Japanese and Non-Japanese Patients: A Meta-Analysis of Oncology Trials.

artículo científico publicado en 2017

Relationship between everolimus exposure and safety and efficacy: meta-analysis of clinical trials in oncology.

artículo científico publicado en 2013

Relay chemotherapy using continuous perfusion of cisplatin and fluoro-uracil in advanced cancer of the breast. Analysis of a series of 50 cases

artículo científico publicado en 1990

Renal involvement in cancer and renal paraneoplastic syndromes

artículo científico publicado en 2012

Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group

artículo científico publicado en 1999

Role of adjuvant chemotherapy in the treatment of soft tissue sarcoma

artículo científico publicado el 1 de junio de 1997

Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours

artículo científico publicado en 2014

Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA Cohort

artículo científico publicado en 2015

Sequential sorafenib and sunitinib for renal cell carcinoma.

artículo científico publicado en 2009

Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma.

artículo científico publicado en 2018

Sorafenib dose escalation in treatment-naïve patients with metastatic renal cell carcinoma: a non-randomised, open-label, Phase 2b study.

artículo científico publicado en 2016

Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma.

artículo científico publicado en 1994

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

scientific article published on 03 June 2018

Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas

artículo científico publicado en 2017

Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohort

artículo científico publicado en 2013

Symptomatic neurological epidural metastasis with interleukin-2 therapy in metastatic renal cell carcinoma

artículo científico publicado en 2002

Systemic therapy of renal cell carcinoma.

artículo científico publicado en 2014

Targeted therapies in non-muscle-invasive bladder cancer according to the signaling pathways

artículo científico publicado en 2009

Targeted therapy and elderly people: A review.

artículo científico publicado en 2016

Targeted therapy for locally advanced and/or metastatic bladder cancer

artículo científico publicado en 2008

Taxane-induced glaucoma

artículo científico publicado en 1999

Ten-year experience of percutaneous image-guided radiofrequency ablation of malignant renal tumours in high-risk patients

artículo científico publicado en 2013

The experimental renal cell carcinoma model in the chick embryo

artículo científico publicado en 2012

The role of surgery for metastatic renal cell carcinoma in the era of targeted therapies

artículo científico publicado en 2013

Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux

artículo científico publicado en 2009

Therapy management with sunitinib in patients with metastatic renal cell carcinoma: key concepts and the impact of clinical biomarkers.

artículo científico

Tivozanib: is total VEGFR inhibition the way to success in terms of tolerability and efficacy in advanced kidney cancer?

artículo científico publicado en 2012

Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025.

artículo científico

Treatment of spinal metastases in renal cell carcinoma: A critical review

scientific article published on 06 March 2018

Treatment-associated adverse event management in the advanced renal cell carcinoma patient treated with targeted therapies.

scientific article published on January 2011

Trebananib (AMG 386) in Combination With Sunitinib in Patients With Metastatic Renal Cell Cancer: An Open-Label, Multicenter, Phase II Study.

artículo científico publicado en 2015

Tyrosine-kinase inhibitors in the treatment of muscle invasive bladder cancer and hormone refractory prostate cancer

artículo científico publicado el 1 de noviembre de 2010

UFT and oral calcium folinate as first-line chemotherapy for metastatic gastric cancer

artículo científico publicado en 1999

Update on the medical treatment of metastatic renal cell carcinoma

artículo científico publicado en 2008

VEGFR TKI 'resistance' or transient clinical insensitivity to VEGFR TKI in metastatic renal cell carcinoma

artículo científico publicado en 2009

Validation of the 16-Gene Recurrence Score in Patients with Locoregional, High-Risk Renal Cell Carcinoma from a Phase III Trial of Adjuvant Sunitinib

article

Vinorelbine/5-FU combination in metastatic breast cancer chemotherapy. A retrospective study of 63 cases

artículo científico publicado en 1996

[Alternative prescription schedules of sunitinib in metastatic kidney cancer: from the underground to the light?]

artículo científico publicado en 2014

[Bladder cancer. Editorial]

artículo científico publicado en 2010

[Cancer of the prostate: recent findings and the immediate future]

artículo científico publicado en 2007

[Cell therapy in solid tumors]

scientific article published on 01 January 2001

[Does surgery promote the development of metastasis in melanoma?]

artículo científico publicado en 2000

[Is the incidence of painless chronic pancreatitis underestimated?]

scientific article published on 01 June 1989

[Management of muscle invasive bladder in elderly]

artículo científico publicado en 2010

[Management of side effects of targeted therapies in renal cancer: iatrogenic side effects]

artículo científico publicado en 2011

[Neoadjuvant chemotherapy and combined conservative treatment of soft tissue sarcoma in the adult]

artículo científico publicado en 1992

[Not value to the systematic study of different tumor markers for disclosing bone metastasis]

[Perception of cancer by general practitioners. Development over 15 years]

artículo científico publicado en 1993

[Prostate carcinoma in the elderly]

scientific article published on 01 May 2008

[Radiofrequency ablation in the treatment of liver and lung tumors]

artículo científico publicado en 2009

[Refining the French system of cost assessment for oncology patients following chemotherapy]

scientific article published on 01 November 2003

[Renal cell carcinoma: the end of a tunnel?]

scientific article published on 10 March 2006

[Revision of therapeutic index for targeted treatment in kidney cancer: What if toxicity could predict efficacy?]

artículo científico publicado en 2014

[Strategy in advanced castration-resistant prostate cancer]

artículo científico publicado en 2012

[Study of bioavailability parameters of propranolol in cirrhotic patients after oral administration of the delayed-action form]

artículo científico publicado en 1987

[Symptomatic treatment of pain in cervico-facial cancers]

artículo científico publicado en 1992

[Systemic chemotherapy in metastatic colorectal adenocarcinomas]

artículo científico publicado en 1992

[The mechanism of tumor angiogenesis]

scientific article published on 01 February 2007

[Treatment of cancer of the kidney with interleukin 2 in adults, the Lyon experience]

artículo científico publicado en 1992

[Update on renal cell carcinoma]

scientific article published on 01 January 2002

m-TOR inhibitor as potential radiosensitizer for head and neck squamous cell carcinoma: A case report of an organ transplant patient and review of the literature

artículo científico publicado en 2016

mTOR inhibitors: temsirolimus and everolimus in the treatment of renal cell carcinoma

artículo científico publicado en 2010

Eficacia de everolimus en el carcinoma avanzado de células renales: ensayo de fase III, doble ciego, aleatorizado y controlado con placebo

artículo científico publicado en 2008

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda